Category Archives: Hyperbaric Medicine

Even with technological advancements, researchers have difficulty treating aging among humans. But the high-tech tool known as CRISPR, gene-editing equipment, shows a promising result in curing rapid aging within humans. However, science does not seem to dwell sometimes with technology, and the possible solution to slow or even reverse aging could already be an outdated method Continue reading →

Regenerative Medicine market report elucidates the recent trends in the industry space with respect to various segments, and region, alongside thorough scrutiny of Covid-19 impact. Request a sample Report of Regenerative Medicine Market at:https://www.marketstudyreport.com/request-a-sample/3431311?utm_source=neighborwebsj.com&utm_medium=AG Objective The Regenerative Medicine market research report covers all aspects pertaining to this verticals growth over 2020-2027. Moreover, it highly emphasizes on the production and consumption facets to offer a strong indication of the path that this industry will follow in the coming years Continue reading →

The latest report entitled Global Veterinary Hyperbaric Chambers Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 from MarketsandResearch.biz evaluates the industry prospects, competition, product demand, application popularity from 2015-2025. Continue reading →

Hyperbaric oxygen therapy, or HBOT, is a type of treatment used to speed up healing of carbon monoxide poisoning, gangrene, stubborn wounds, and infections in which tissues are starved for oxygen. If you undergo this therapy, you will enter a special chamber to breathe in pure oxygen in air pressure levels 1.5 to3 times higher than average. Continue reading →

Facebook Linkedin Pinterest Print Skin Burns Hyperbaric oxygen therapy involves exposing the body to 100% oxygen at a pressure that is greater than normal. . Wounds need oxygen to heal properly. Exposing a wound to 100% oxygen may speed healing Continue reading →

You may have walked past the nondescript building at the southeast corner of the Kuakini campus, not realizing that it houses an essential resource for our state. The Hyperbaric Treatment and Wound Care Center (HTC), Hawaiis dive chamber, has been providing life- and limb-saving hyperbaric oxygen therapy (HBOT) for over 37 years, now celebrating its 25th anniversary at its present location at Hale Pulama Mau. The unassuming facade belies its importance as the only emergency hyperbaric chamber in the state, serving the most critical patients in need of HBOT, and an essential safety net for military and commercial operations. Continue reading →

A newly added research report by Orbis Pharma Reports evaluating various developments and eventful milestones in global Hyperbaric Oxygen Therapy (HBOT) Clinics market suggests that the aforementioned market is an emerging one with ample scope for refurbishments and developments. Inclined to render optimum investment guidance for accurate pandemic management, this versatile research report also sheds ample light on COVID-19 pandemic management and evolution guide to emerge successfully from limitations that have stunned growth progression substantially Continue reading →

KINGSPORT Holston Valley Medical Center was the only United States hospital selected as a demonstration site for this years Leipzig Interventional Course (LINC). Dr Continue reading →

Credit: Shamir Medical Center Study finds hyperbaric oxygen treatments halt the aging of blood cells and reverses the aging process. A new study from Tel Aviv University (TAU) and the Shamir Medical Center in Israel indicates that hyperbaric oxygen treatments (HBOT) in healthy aging adults can stop the aging of blood cells and reverse the aging process. In the biological sense, the adults blood cells actually grow younger as the treatments progress. Continue reading →

Brian Mac Grory, MB BCh BAO, has won the American Heart Association/ American Stroke Association's 2020 Stroke Progress and Innovation Award (first place) for his research examining treatment for central retinal artery occlusion (CRAO), a rare type of stroke affecting the eye. The study performed by Mac Grory and colleagues found that clot-busting medications, if given within 4.5 hours after the eye stroke, improved the chances of vision recovery for patients with CRAO. This research, published July in Stroke, offers the best observational evidence for treating CRAO with thrombolysis that is currently available. Continue reading →